Cleared Traditional

K093269 - PROCEDURE REHEARSAL STUDIO

K093269 is an FDA 510(k) clearance for PROCEDURE REHEARSAL STUDIO, manufactured by Simbionix , Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 305-day FDA review.

K093269 · Simbionix , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
305d
Days
Class 2
Risk

K093269 is an FDA 510(k) clearance for the PROCEDURE REHEARSAL STUDIO. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Simbionix , Ltd. (Chalotte, US). The FDA issued a Cleared decision on August 20, 2010 after a review of 305 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Simbionix , Ltd. devices

FDA 510(k) Submission Details - K093269

510(k) Number K093269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2009
Decision Date August 20, 2010
Days to Decision 305 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
198d slower than avg
Panel avg: 107d · This submission: 305d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1268
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K093269.
SYNGO DYNAMICS, VERSION 9.0
K102150 · Siemens Medical Solutions USA, Inc. · Oct 2010
EP NAVIGATOR R3
K101311 · Philips Medical Systems North America Co. · Sep 2010
ENSITE VERISMO SEGMENTATION TOOL V.2.0
K101697 · St Jude Medical · Sep 2010
21.3 (54 CM) MONOCHROME DIGITAL MAMMOGRAPHY LCD MONITOR, MODEL MS3112 (MDL2128A)
K090947 · Totoku Electric Co., Ltd. · Aug 2010
SYNGO. PLAZA VA20A
K101666 · Siemens AG Medical Solutions · Aug 2010
SYNAPSE 3D BASIC TOOLS
K101662 · Fujifilm Medical System U.S.A., Inc. · Jul 2010